Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02743637
Title A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors (SDX-0101)
Acronym SDX-0101
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors SynDevRx, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.